{"id":"https://openalex.org/W2597837743","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13503","title":"Development of a new equation to estimate GFR in cancer patients.","display_name":"Development of a new equation to estimate GFR in cancer patients.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2597837743","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13503","mag":"2597837743"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.e13503","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13503","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13503","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063797971","display_name":"Michael Patvin Chu","orcid":"https://orcid.org/0000-0002-2826-3342","observed_orcids":["https://orcid.org/0000-0002-2826-3342"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michael Patvin Chu","raw_affiliation_strings":["Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047","https://openalex.org/I4405258411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083589557","display_name":"Larissa McCaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Larissa McCaw","raw_affiliation_strings":["Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047","https://openalex.org/I4405258411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069753245","display_name":"Cynthia Stretch","orcid":"https://orcid.org/0000-0002-5152-2728","observed_orcids":["https://orcid.org/0000-0002-5152-2728"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Cynthia Stretch","raw_affiliation_strings":["Department of Oncology, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110853292","display_name":"John Hanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"John Hanson","raw_affiliation_strings":["Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047","https://openalex.org/I4405258411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065628639","display_name":"Michelle Kuzma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michelle Kuzma","raw_affiliation_strings":["Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047","https://openalex.org/I4405258411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045280265","display_name":"Vijaya L. Damaraju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vijaya L. Damaraju","raw_affiliation_strings":["University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010704818","display_name":"Vickie Elaine Baracos","orcid":"https://orcid.org/0000-0002-9609-1001","observed_orcids":["https://orcid.org/0000-0002-9609-1001"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vickie E. Baracos","raw_affiliation_strings":["Department of Oncology, University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074419775","display_name":"Michael B. Sawyer","orcid":"https://orcid.org/0000-0002-2640-3620","observed_orcids":["https://orcid.org/0000-0002-2640-3620"]},"institutions":[{"id":"https://openalex.org/I4405258411","display_name":"Cross Cancer Institute","ror":"https://ror.org/00m3k3802","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405258411"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michael B. Sawyer","raw_affiliation_strings":["Cross Cancer Institute, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cross Cancer Institute, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I4405258411"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"e13503","last_page":"e13503"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.03929999843239784,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gfr-estimation","display_name":"glomerular filtration rate estimation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.6579999923706055},{"id":"https://openalex.org/keywords/lean-body-mass","display_name":"lean body mass","score":0.8610000014305115},{"id":"https://openalex.org/keywords/carboplatin-dosing","display_name":"carboplatin dosing","score":0.9319999814033508},{"id":"https://openalex.org/keywords/calvert-formula","display_name":"Calvert formula","score":0.652999997138977},{"id":"https://openalex.org/keywords/cockcroft-gault-equation","display_name":"Cockcroft-Gault formula","score":0.8550000190734863},{"id":"https://openalex.org/keywords/ckd-epi-equation","display_name":"CKD-EPI equation","score":0.7620000243186951},{"id":"https://openalex.org/keywords/mdrd-equation","display_name":"MDRD equation","score":0.8849999904632568},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8849999904632568},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.6299999952316284},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.9336098432540894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8384101390838623},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7930112481117249},{"id":"https://openalex.org/C2777501473","wikidata":"https://www.wikidata.org/wiki/Q1796666","display_name":"Body surface area","level":2,"score":0.6952248811721802},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.6461713314056396},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6215344071388245},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.518541157245636},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5146275758743286},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.45610079169273376},{"id":"https://openalex.org/C120863210","wikidata":"https://www.wikidata.org/wiki/Q17064264","display_name":"Lean body mass","level":3,"score":0.4505036175251007},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4198342561721802},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36752983927726746},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.34752610325813293},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3236303925514221},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.24268034100532532},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.14991113543510437}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.e13503","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13503","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e13503","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4233897325","https://openalex.org/W2890819525","https://openalex.org/W3023592146","https://openalex.org/W2726644013","https://openalex.org/W4414348211","https://openalex.org/W2010357278","https://openalex.org/W2246484986","https://openalex.org/W2046293377","https://openalex.org/W2803468061","https://openalex.org/W2151917263"],"abstract_inverted_index":{"e13503":[0],"Background:":[1],"Renal":[2],"function":[3],"affects":[4],"chemotherapy":[5,251],"pharmacokinetics.":[6],"Carboplatin":[7],"dosing":[8,111,166],"by":[9,84,93,217],"Calvert\u2019s":[10],"formula":[11,234,259],"is":[12,41,225],"more":[13,227],"pharmacologically":[14],"rational,":[15],"but":[16],"requires":[17,28],"an":[18,34],"accurate":[19],"glomerular":[20],"filtration":[21],"rate":[22],"(GFR).":[23],"Calvert":[24],"argues":[25],"that":[26,206,240],"this":[27,47,258],"measuring":[29],"GFR":[30,36],"(mGFR)":[31],"instead":[32],"of":[33,167,182,210],"estimated":[35],"(eGFR).":[37],"Considering":[38],"skeletal":[39],"muscle":[40],"the":[42,178,183,196,220],"major":[43],"source":[44],"for":[45,127,235,250],"creatinine,":[46],"study":[48],"looks":[49],"to":[50,91,243,256],"develop":[51],"a":[52,232],"new":[53,221,233],"eGFR":[54,92,114,151,157,198,223,236],"equation":[55],"in":[56,119,207,237],"cancer":[57,71,238],"patients":[58,72,126,172,239],"using":[59,173],"lean":[60],"body":[61],"mass":[62],"(LBM).":[63],"Methods:":[64],"We":[65,230],"prospectively":[66],"followed":[67],"22":[68],"stage":[69,169],"IV":[70,170],"(10":[73],"female,":[74],"12":[75],"male;":[76],"median":[77,193],"age":[78],"69)":[79],"who":[80],"received":[81],"carboplatin.":[82],"mGFR":[83,138,146],"24":[85],"hr":[86],"creatinine":[87],"clearance":[88],"was":[89,115,187,199],"compared":[90,117],"Wright,":[94],"Cockcroft-Gault":[95],"(CG),":[96],"CKD-EPI,":[97],"MDRD":[98],"and":[99,132,142,175,246,253],"CT-determined":[100],"LBM":[101,150,174,197,222],"(eGFR":[102],"=":[103],"[Muscle":[104],"Surface":[105],"Area":[106],"X":[107],"42]/CR).":[108],"Simulated":[109],"carboplatin":[110,165,185,212],"with":[112,137,149,159],"each":[113],"then":[116],"retrospectively":[118],"100":[120,168],"Non-Small":[121],"Cell":[122],"Lung":[123],"Cancer":[124],"(NSCLC)":[125],"accuracy.":[128],"Results:":[129],"MDRD,":[130],"CG,":[131],"Wright":[133],"equations":[134],"correlated":[135,148],"variably":[136],"(R2":[139,152],"0.47,":[140],"0.57,":[141],"0.69":[143],"respectively).":[144],"Conversely,":[145],"strongly":[147],"0.84).":[153],"The":[154],"Table":[155],"compares":[156],"calculations":[158],"mean":[160,179],"residual":[161,180],"error.":[162],"In":[163],"simulated":[164],"NSCLC":[171],"CG":[176,218],"eGFR,":[177],"error":[181],"CG-determined":[184],"dose":[186,213],"10%":[188],"(0.5%":[189],"min,":[190],"max":[191],"39.7%,":[192],"9.3%),":[194],"assuming":[195],"better":[200],"at":[201],"estimating":[202],"eGFR.":[203],"This":[204],"means":[205],"approximately":[208],"half":[209],"patients,":[211],"may":[214,247],"be":[215],"incorrect":[216],"if":[219],"method":[224],"truly":[226],"accurate.":[228],"Conclusions:":[229],"propose":[231],"appears":[241],"superior":[242],"current":[244],"formulas":[245],"have":[248],"implications":[249],"efficacy":[252],"toxicity.":[254],"Studies":[255],"validate":[257],"are":[260],"under":[261],"way.":[262],"[Table:":[263],"see":[264],"text]":[265]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}